Results 201 to 210 of about 1,776,410 (270)

Sensitivity and Criterion Validity of ED100K Lifetime Eating Disorder Diagnoses: A Study Using a National Eating Disorder Quality Register

open access: yesInternational Journal of Eating Disorders, EarlyView.
ABSTRACT Background Epidemiological and genomic studies of eating disorders (ED) require scalable approaches to case ascertainment. The self‐report ED100K questionnaire assesses lifetime ED diagnoses, has been translated into several languages, and has been used in large cohort studies, with data shared or planned for sharing through major repositories
Hunna J. Watson   +6 more
wiley   +1 more source

Recognizing, Experiencing, and Navigating Eating Disorder Echo Chambers on TikTok: A Qualitative Study

open access: yesInternational Journal of Eating Disorders, EarlyView.
ABSTRACT Background Echo chambers are algorithmically curated environments characterized by reduced informational diversity and repeated exposure to content that reinforces existing attitudes and behaviors. Emerging research suggests TikTok's recommendation algorithm amplifies eating disorder (ED)‐related content among individuals with EDs, creating ED
Wahidah Pan   +4 more
wiley   +1 more source

Disordered Eating Symptom Profiles in Low‐Income, Racially Minoritized Adults

open access: yesInternational Journal of Eating Disorders, EarlyView.
ABSTRACT Objective Eating disorder (ED) research has traditionally assumed that symptoms cluster in the same way across populations. If this assumption is incorrect, models and assessment tools developed with advantaged samples may miss substantial symptom burden in marginalized populations.
Megan E. Mikhail   +4 more
wiley   +1 more source

Disordered Eating Attitudes and Behaviors in Individuals With BMI > 27 kg/m2 Treated by Semaglutide: A 60‐Week Randomized Placebo‐Controlled Trial

open access: yesInternational Journal of Eating Disorders, EarlyView.
ABSTRACT Objective To examine disordered eating attitudes and behaviors in individuals treated with semaglutide 2.4 mg or placebo for 60 weeks. Methods Individuals seeking obesity treatment (n = 120) randomized (3:2) to semaglutide or placebo, both with lifestyle intervention, were assessed at baseline and Weeks 20, 40, and 60.
Kelly C. Allison   +6 more
wiley   +1 more source

Disordered Minds, Disordered Meals: When Emotions Masquerade as Hunger in Eating Disorders-A Systematic Review. [PDF]

open access: yesNutrients
Marano G   +11 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy